GoodRx Holdings (GoodRx Holdings) ROCE % : -2.57% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is GoodRx Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. GoodRx Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was -2.57%.

GoodRx Holdings ROCE % Historical Data

The historical data trend for GoodRx Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GoodRx Holdings ROCE % Chart

GoodRx Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

40.68

-31.24

0.92

0.72

0.08

GoodRx Holdings Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															1.91	4.36	6.63	-7.97	-2.57

GoodRx Holdings ROCE % Calculation

GoodRx Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	1.156	/	( ( (1604.631 - 76.32)	+	(1588.8 - 122.559) )	/ 2 )
	=	1.156	/	( (1528.311	+	1466.241)	/ 2 )
	=	1.156	/	1497.276
	=	0.08 %

GoodRx Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-39.256	/	( ( (1707.972 - 117.822)	+	(1588.8 - 122.559) )	/ 2 )
	=	-39.256	/	( ( 1590.15	+	1466.241 )	/ 2 )
	=	-39.256	/	1528.1955
	=	-2.57 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

GoodRx Holdings (NAS:GDRX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

GoodRx Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of GoodRx Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

GoodRx Holdings (GoodRx Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GoodRx Holdings Inc (NAS:GDRX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2701 Olympic Boulevard, Santa Monica, CA, USA, 90404

Website

https://www.goodrx.com

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers other healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Executives

Scott Wagner	officer: Interim Chief Executive Office	C/O WILSON SONSINI GOODRICH AND ROSATI, 650 PAGE MILL ROAD, PALO ALTO CA 94304
Raj Beri	officer: Chief Operating Officer	C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Romin Nabiey	officer: Chief Accounting Officer	C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Andrew Slutsky	officer: President & Consumer	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Idea Men, Llc	10 percent owner	2701 OLYMPIC BOULEVARD, WEST BUILDING - SUITE 200, SANTA MONICA CA 90404
Karsten Voermann	officer: Chief Financial Officer	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Trevor Bezdek	director, officer: Co-CEO	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Abdiel Qualified Master Fund Lp	10 percent owner	90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Douglas Joseph Hirsch	director, officer: Co-CEO	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Babak Azad	officer: See Remarks	233 WILSHIRE ROAD, SANTA MONICA CA 90410
Bansi Nagji	officer: President, Healthcare	MCKESSON CORPORATION, 6555 STATE HIGHWAY 161, IRVING TX 75039
Agnes Rey-giraud	director
Abdiel Capital Lp	10 percent owner	C/O ABDIEL CAPITAL ADVISORS, LP, 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Advisors, Lp	10 percent owner	90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Management, Llc	10 percent owner	90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016